Carregant...
Prevalence and determinants of cervical cancer screening with a combination of cytology and Human Papillomavirus testing
PURPOSE: In the US, recommended options for cervical cancer screening in women aged ≥ 30 years include cytology alone, and a combination of cytology and Human Papillomavirus (HPV) testing (co-testing). While there is a body of evidence suggesting that co-testing may be the preferred screening option...
Guardat en:
| Publicat a: | Ann Epidemiol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6732232/ https://ncbi.nlm.nih.gov/pubmed/31320153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annepidem.2019.06.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|